Stem cell bond issue has narrow lead in poll
By Associated Press,
Associated Press
| 10. 11. 2004
A controversial measure that would provide $3 billion in state bond money to pay for human embryonic stem cell research holds a narrow margin of support among voters, according to a new Field Poll.
Proposition 71, designed to get around the Bush administration's funding limits on such research, would authorize the state to sell bonds to provide annual payments of about $300 million to scientists and companies doing stem cell research.
The poll found that 46 percent of likely voters support the idea with 39 percent opposed and 15 percent undecided. The margin of error was 4.3 percentage points.
The numbers are a slight improvement from an August poll that found 45 percent supported the bond measure to 42 percent opposed.
Supporters of the proposition -- including a coalition of influential Democratic donors and several Silicon Valley tycoons -- have raised more than $12 million for the campaign and are running TV ads.
The Field Poll found that half of those surveyed said they had seen or heard something about the initiative -- an improvement since August of 10 percentage...
Related Articles
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...
By Virginia Heffernan, The New Republic | 05.29.2026
Here and there, it’s been a good month for humanity—or “magnificas humanitas,” as Pope Leo XIV calls us poor featherless bipeds.
On May 25, the pope published his encyclical letter “on safeguarding the human person in the time of artificial...